News for Nature's Sunshine Products, Inc. (NATR)

Nature's Sunshine Products (NATR) renews a $200,000 scholarship fund with the University of Utah's David Eccles School of Business for the Opportunity Scho

**media[649657,649658,649659]**

DA Davidson analyst Linda Bolton Weiser has maintained a 'Buy' rating on Nature's Sunshine Products (NATR), a company listed on the NASDAQ, as of June 3, 2025.

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NNATR.OQ - Nature's Sunshine Products IncQ1 2025 Nature's Sunshine Products Inc Earnings CallMa

Nature's Sunshine Products, Inc. (NATR) reaffirms its fiscal year 2025 adjusted EBITDA projection, targeting a range of $38 million to $44 million. The company

Nature's Sunshine Products' digital strategies and Asia-Pacific market success should sustain revenue growth. Read why NATR stock is a Buy.

**media[614542,614543]**

LEHI, Utah, April 24, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. ( NATR), a leading manufacturer of high-quality herbal and nutritional supplem

**media[604908]**

LEHI, Utah, April 24, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. ( NATR), a leading manufacturer of high-quality herbal and nutritional supplem

Nature's Sunshine Products (NATR) to hold Q1 2025 earnings call on May 6, 2025. Conference call scheduled at 5:00 p.m. Eastern time, res

**media[602245]**

**media[577472]**

Ironwood Pharmaceuticals (IRWD) recently experienced a significant stock price drop of 5.20%, bringing its share price to $3.58. The trading volume reached 431,

**media[482476]**

**media[462600,462601]**

Nature's Sunshine Products, Inc. (NASDAQ:NATR) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ETCompany ParticipantsNate Brower - General...

The following slide deck was published by Nature's Sunshine Products, Inc.

Nov 07, 2024 / 10:00PM GMTOperator Good afternoon, everyone. And thank you for participating in today's conference call to discuss Nature's Sunshine's financial